NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN



Similar documents
Intertrust N.V. announces the indicative price range, offer size, start of offer period and publication of prospectus of its planned IPO

Financial Report as of September 30, 2015 Third Quarter 2015

Ströer continuing on its profitable course of digital growth in Q3 and significantly raising its guidance for both 2015 and 2016

OW BUNKER ANNOUNCES INTENTION TO LAUNCH AN IPO AND TO SEEK A LISTING ON NASDAQ OMX COPENHAGEN

HelloFresh planning IPO


Management Board Chairman Dr. Marijn Dekkers at the Annual Stockholders Meeting of Bayer AG:

Full Year Results 2014

SAF-HOLLAND Annual Financial Statements Detlef Borghardt, CEO Wilfried Trepels, CFO. March 14, 2013

Capio intends to be listed on the Nasdaq Stockholm Stock Exchange

EMA Reaffirms Positive Benefit-Risk Balance of Bayer s Xarelto for Stroke Prevention in Patients with Atrial Fibrillation

Focus on fleet customers SAF-HOLLAND Annual Financial Statements 2013

Bayer Extends Clinical Investigation of Xarelto for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer

Consolidated Interim Report

MALAKOFF FIRED UP FOR LISTING ON BURSA MALAYSIA

Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention

Concentration on core business leads to one-off effects in first quarter results of SCHMOLZ + BICKENBACH

Q1/2015 Results VTG AG Connecting worlds. Dr. Heiko Fischer, CEO Dr. Kai Kleeberg, CFO May 21, 2015

Full Year Results Conference Call Presentation, 21 st March 2013

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA.

Performance Food Group Company Reports First-Quarter Fiscal 2016 Earnings

VOLEX INTERIM RESULTS TO OCTOBER Christoph Eisenhardt, CEO Nick Parker, CFO November 2014

Ludwigshafen, February 25, 2014

P R E S S R E L E A S E K E N D R I O N N. V. 7 M A Y

INVESTMENT CASE FULLY INTACT

Unaudited Nine Months Financial Report

As the selling shareholder, Novo Nordisk A/S will receive all the net proceeds from the offering.

euromicron AG Corrections to financial statements Hold EUR

SBERBANK GROUP S IFRS RESULTS. March 2015

Full Year 2015 Results

Sberbank Group s IFRS Results for 6 Months August 2013

Third Quarter 2015 Earnings Conference Call. 21 August 2015

Annual Press Conference March 2015

Conference call on 2014 half year results 13 August 2014

NICKEL MOUNTAIN GROUP AB

Software AG Results 1 st Quarter 2015 (IFRS, unaudited)

In 2014 UNIWHEELS continued to improve its financial results

RUNNINGBALL ACQUISITION INVESTOR PRESENTATION

New Real-World Evidence Reaffirms Low Major Bleeding Rates for Bayer s Xarelto in Patients with Non-Valvular Atrial Fibrillation

Hot Line Session at European Society of Cardiology (ESC) Congress 2014:

FOSSIL GROUP, INC. REPORTS FOURTH QUARTER AND FISCAL YEAR 2014 RESULTS; Fourth Quarter Net Sales of $1.065 Billion; Diluted EPS Increases 12% to $3.

Ahlers AG, Herford. ISIN DE and DE INTERIM REPORT

Investor News. Phase III J-ROCKET AF Study of Bayer s Xarelto (rivaroxaban) Meets Primary Endpoint. Not intended for U.S.

Earnings Release Q3 FY 2015 April 1 to June 30, 2015

Bank of America Merrill Lynch 2013 Banking & Financial Services Conference. Robert J. McCann CEO, UBS Group Americas CEO, Wealth Management Americas

Intertrust N.V. announces intention to proceed with Initial Public Offering on Euronext Amsterdam

BOŚ S.A. GROUP Q3 2012

Financial Results. siemens.com

Earnings Release Q1 FY 2016 October 1 to December 31, 2015

First Quarter 2015 Earnings Conference Call. 20 February 2015

2OO 6 9 MONTHS REPORT 2OO 7

Klöckner & Co SE. Q Results

Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of Unmet Medical Need in Arterial Thromboembolism

Background information. Changes in the shareholder structure and balance sheet. Contract with Google prolonged for two years

INTENTION TO FLOAT ( ITF ) Press release, 14/01/2014

Sales and profit expectations for 2014 fulfilled Distribution proposed Share buy-back agreed

Conference Call. WASHTEC AG H Report

Statement by Kasper Rorsted Chairman of the Management Board Conference-Call August 12, 2015, a.m.

Sales increased 15 percent to $4.5 billion Earnings per Share increased 37 percent to $0.96 Operating Cash Flow increased 22 percent to $319 million

Pfaeffikon SZ, 1 April 2010 Oerlikon Group today announces that it has reached agreement on the terms of a set of comprehensive financial

Unaudited Financial Report

FOSSIL GROUP, INC. REPORTS THIRD QUARTER 2014 RESULTS. Third Quarter Net Sales Increase 10% to $894 Million; Diluted EPS Increases 24% to $1.

Full-year results December 02, 2014

Hoist Finance announces its intention to launch an initial public offering and listing on Nasdaq Stockholm

Investor News. Not intended for U.S. and UK media

- 2/5 - September 16, This page is intentionally left blank

Service Tax Planning - Expected Revenue Growth in FY 2015

Debt Investor Update March 2013

For Immediate Release. Superior Plus Corp. to Acquire Canexus Corporation Enhancing and Expanding the Specialty Chemicals Platform

Media Contact: Mike Conway Director, Corporate Communications Sherwin-Williams Direct: Pager:

Pfeiffer Vacuum announces results for FY 2014

AIMS AMP CAPITAL INDUSTRIAL REIT CLOSE OF PRIVATE PLACEMENT OF NEW UNITS

PRESS RELEASE WACKER ACHIEVES STRONG SALES GROWTH IN Q WITH EARNINGS BELOW PREVIOUS YEAR DUE TO LOWER SPECIAL INCOME.

Herzogenaurach, Germany, July 27, 2004 PUMA AG announces its consolidated nd

Company Presentation VTG AG Connecting worlds. Analyst Conference April 14, 2015

Fiscal Year Guidance Achieved Execution of Vision 2020 Begun

24/ 01 / EUR 5.5 bn CAPITAL INCREASE

ITW Conference Call Third Quarter 2013

Polyurethanes. Narrower and Deeper into Growth Markets. Glenn Wright Business President, Polyurethanes Group. March 15, The Dow Chemical Company

Third quarter results FY2015. August 17, 2015

ROFIN-SINAR REPORTS RESULTS FOR THE FIRST QUARTER OF FISCAL YEAR 2016

PEGAS NONWOVENS SA. First quarter 2010 unaudited consolidated financial results

How To Profit From Trailer Production

DATRON AG. Investor day supports our positive view. Buy (Buy) EUR (12.50 EUR ) BANKHAUS LAMPE // 1 17/09/2015

HAMBURGER HAFEN UND LOGISTIK AG

Full Year Report January 2006

WILLIAMS-SONOMA, INC.

Currency-neutral sales growth Earnings hurt by change in production and strong Swiss franc

CENIT AG Systemhaus. Industriestraße D Stuttgart Tel: Fax: Internet:

NOMAD FOODS LIMITED ANNOUNCES FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2016

Not for distribution in the United States, Canada, Australia or Japan

ACADIAN TIMBER CORP. REPORTS FOURTH QUARTER AND YEAR-END RESULTS

Airbus Group Achieves Record Revenues, EBIT* And Order Backlog In 2014

FONDUL PROPRIETATEA S.A.

Nordic Waterproofing announces its initial public offering on Nasdaq Stockholm and prospectus in connection therewith

Third Quarter 2014 Earnings Conference Call. 13 August 2014

Interim Management Statement November 19, 2013

Formation of Amlin Bermuda and rights issue to raise 215 million (net) November 2005

Cytec Announces First Quarter 2010 Results. As-Adjusted EPS of $0.66, Significantly Above Prior Year As-Adjusted EPS of $0.06

Telesat Reports Results for the Quarter and Year Ended December 31, 2014

Transcription:

Investor News NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN Bayer plans IPO for Covestro Listing on Frankfurt Stock Exchange intended in Q4 2015 Capital increase in the form of new shares issued by Covestro Potential for growth in profitability and cash generation Covestro targets investment-grade credit rating Dividend payout ratio of 30 to 50 percent of net income envisaged Leverkusen, Germany, September 4, 2015 Bayer has taken the decision to proceed with an Initial Public Offering (IPO) of Covestro AG ( Covestro ), a world-leading polymers company formerly known as Bayer MaterialScience. Covestro will seek a listing in the regulated market segment (Prime Standard) of the Frankfurt Stock Exchange. The offering will consist solely of new shares issued by Covestro by way of a capital increase. They will be offered publicly in Germany and Luxembourg to private and institutional investors. Outside of these countries, shares will be offered by way of private placements. Subject to capital market conditions, Covestro s IPO is expected to be completed in the fourth quarter of 2015. Covestro intends to use the proceeds from the IPO primarily to repay intercompany debt to Bayer and in this way to establish its target capital structure. With net debt including pension liabilities at 2.5 to 3.0 times adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) for fiscal 2015, Covestro is seeking an investment-grade credit rating. - 1/5 -

Dekkers: Clear benefits for Bayer and Covestro Dr. Marijn Dekkers, CEO of Bayer AG, said: We have been evaluating the optimal way for the separation of the MaterialScience business and believe that an IPO delivers clear benefits for both Bayer and Covestro and their stakeholders. This transaction will allow both businesses to pursue their strategic goals. Covestro s IPO is a further step in the transition to an independent company. It will give us the opportunity to build our position as a pure-play polymers producer with strong competitive advantages, said Patrick Thomas, CEO of Covestro. We are confident that investors will welcome the opportunity to invest in a market-leading, focused business through this transaction. Positive growth perspective Based on independent research, Covestro s markets are expected to grow at rates above global GDP on the back of macro trends such as climate change, growing mobility and increasing urbanization. To address these trends, the company provides and will continue to develop for example products for the insulation of buildings and cooling devices, for lightweight construction in the transportation sector and for the production of solvent-free coatings and adhesives. The company s leading process technology as well as its extensive and well-invested asset base provide it with a highly competitive cost position. Customer proximity is ensured by its eight world-scale plants in Europe, Asia and the Americas and its global network of technical centers offering customized solutions. Covestro is aiming for mid-term growth of its net sales and adjusted EBITDA. According to the Combined Financial Statements, the company achieved net sales of EUR 11.761 billion and adjusted EBITDA of EUR 1.161 billion in fiscal 2014. Its financial outlook is driven by increasing utilization of its asset base and a disciplined cost focus. The anticipated growth in demand is expected to result in higher utilization of recently expanded capacities. A limited need for new asset investment should further support growth in free cash flow. In addition, Covestro plans to align overall costs with best-in-class chemical industry - 2/5 -

benchmarks. This together with targeted asset optimization is expected to generate total gross savings of around EUR 420 million by 2019. Strong financial performance in the first half of 2015 The company s competitiveness is illustrated by its strong financial performance in the first half of 2015. Covestro s volumes grew by 4.3 percent compared to the first half of 2014, resulting in net sales growth of 9.5 percent to EUR 6.264 billion according to the Combined Financial Statements. Adjusted EBITDA increased significantly by 46.2 percent to EUR 914 million, also supported by positive currency effects. This resulted in an adjusted EBITDA margin of 14.6 percent, up 3.7 percentage points on the same period last year. Free operating cash flow rose to EUR 321 million, from a negative EUR 85 million during the year-earlier period. Breaking down these results shows that all three business units contributed to this strong performance. At Polyurethanes, net sales were up by just over 5 percent in the first six months of 2015, lifting the adjusted EBITDA margin by 1.3 percentage points to 12.1 percent. Net sales at Polycarbonates rose by almost 18 percent, more than doubling this business unit s adjusted EBITDA margin to 16.7 percent (H1 2014: 6.5 percent). In the Coatings, Adhesives and Specialties business unit, net sales grew by 14.5 percent and the adjusted EBITDA margin increased to 24.6 percent from 23.2 percent in the prioryear period. Sustainable dividend policy envisaged Covestro intends to share its business success with its investors. The company envisages a dividend policy with a payout ratio of 30 to 50 percent based on net income (IFRS) from 2016 onwards. Our efficient capital structure and strong free cash flow are expected to support a sustainable dividend policy, Thomas said. For fiscal 2015, Covestro envisages proposing a total dividend payment of around EUR 100 million to EUR 150 million at the Annual Stockholders Meeting in 2016 provided that the IPO is successfully executed in the fourth quarter of 2015. Covestro has a workforce of more than 16,000 highly skilled and motivated employees and is led by a strong management team with a proven track record and a clear commitment to long-term value creation. - 3/5 -

Leading industry positions, focused portfolio As a long-standing partner of choice for its customers worldwide, Covestro has an 80- year history of developing market-driven, innovative polymers used across a wide range of industries. The company holds prime and defendable global industry positions across its entire portfolio. It operates in businesses that are characterized by distinct entry barriers resulting from significant investment requirements, close customer relationships and long-term research and development collaborations. Among Covestro s inventions are polyurethanes and today the company is the world s largest producer of components for these versatile materials. They are mainly used as flexible and rigid foams in many industries such as the furniture, appliances and construction sectors. The company is also the inventor and one of the biggest suppliers of polycarbonates a high-tech plastic used in key industries such as automotive, electronics and medical technology. An increasingly important pillar of Covestro s business and a solid platform for future development are high-value specialty polymers derived from polyurethanes. These are used to produce coatings, adhesives and specialty chemicals (CAS) for the automotive, construction, textile, cosmetics and other key industries. Covestro is the world s leading developer and manufacturer of these substances, offering more than 2,300 customized products to over 4,300 customers. Joint global coordinators for the envisaged transaction are Deutsche Bank and Morgan Stanley. They are acting as joint bookrunners together with Bank of America Merrill Lynch, Citi, Credit Suisse, JP Morgan and UBS. BNP Paribas and Unicredit / Kepler Cheuvreux have been mandated as co-lead managers. - 4/5 -

Bayer AG, Investor Relations contacts: Dr. Alexander Rosar (+49-214-30-81013) Dr. Jürgen Beunink (+49-214-30-65742) Peter Dahlhoff (+49-214-30-33022) Judith Nestmann (+49-214-30-66836) Constance Spitzer (+49-214-30-33021) Dr. Olaf Weber (+49-214-30-33567) Covestro AG, Investor Relations contacts: Ronald Köhler (+49-214-6009-5098) Ilia Kürten (+49-214-6009-7429) Forward-looking statements This news release may contain forward-looking statements based on current assumptions and forecasts made by Covestro AG. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Covestro s and Bayer s public reports which are available on the Covestro website at www.covestro.com as well as on Bayer AG s website at www.bayer.com. Covestro and Bayer assume no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. Important Information: These materials are not for distribution, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia, Canada or Japan. These materials do not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States, Australia, Canada or Japan. The Shares mentioned herein have not been, and will not be, registered under the US Securities Act of 1933, as amended (the Securities Act ). The Shares may not be offered or sold in the United States, except pursuant to an exemption from the registration requirements of the Securities Act. There will be no public offer of the Shares in the United States. In the United Kingdom, this communication is only being distributed to and is only directed at (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the Order ) or (ii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as relevant persons ). The Shares are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such Shares will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents. This publication constitutes neither an offer to sell nor a solicitation to buy securities. The offer will be made solely by means of, and on the basis of, a securities prospectus which is to be published. An investment decision regarding the publicly offered securities of Covestro AG should only be made on the basis of the securities prospectus. The securities prospectus will be published promptly upon approval by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and will be available free of charge from Covestro AG, 51365 Leverkusen, Germany, or on the Covestro website. - 5/5 -